These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38037889)

  • 1. External quality monitoring facilitates improvement in already well-performing stroke units: insights from RES-Q Poland.
    Karliński M; Kobayashi A; Niewada M; Fryze W; Tomczak A; Brola W; Rejdak K; Luchowski P; Adamkiewicz B; Wiszniewska M; Włodarczyk U; Kaźmierski R; Kram P; Bartosik-Psujek H; Kaczorowski R; Sobolewski P; Fudala M; Gałązka A; Rogoziewicz M; Rogoziewicz A; Sienkiewicz-Jarosz H; Cybulska E; Pożarowszczyk N; Staszewski J; Dębiec A; Horoch-Łyszczarek E; Mączkowiak A; Czlonkowska A
    Neurol Neurochir Pol; 2024; 58(1):75-83. PubMed ID: 38037889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving a door-to-needle time of 25 minutes in thrombolysis for acute ischemic stroke: a quality improvement project.
    Van Schaik SM; Van der Veen B; Van den Berg-Vos RM; Weinstein HC; Bosboom WMJ
    J Stroke Cerebrovasc Dis; 2014; 23(10):2900-2906. PubMed ID: 25263647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital.
    Kamal N; Shand E; Swanson R; Hill MD; Jeerakathil T; Imoukhuede O; Heinrichs I; Bakker J; Stoyberg C; Fowler L; Duckett S; Holsworth S; Mann B; Valaire S; Bestard J
    Can J Neurol Sci; 2019 Jan; 46(1):51-56. PubMed ID: 30516454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.
    Kamal N; Sheng S; Xian Y; Matsouaka R; Hill MD; Bhatt DL; Saver JL; Reeves MJ; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2017 Apr; 48(4):946-954. PubMed ID: 28228574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How registry data are used to inform activities for stroke care quality improvement across 55 countries: A cross-sectional survey of Registry of Stroke Care Quality (RES-Q) hospitals.
    Fasugba O; Sedani R; Mikulik R; Dale S; Vařecha M; Coughlan K; McElduff B; McInnes E; Hladíková S; Cadilhac DA; Middleton S
    Eur J Neurol; 2024 Jan; 31(1):e16024. PubMed ID: 37540834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care.
    Bray BD; Cloud GC; James MA; Hemingway H; Paley L; Stewart K; Tyrrell PJ; Wolfe CD; Rudd AG;
    Lancet; 2016 Jul; 388(10040):170-7. PubMed ID: 27178477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Improved Dysphagia Care on Outcome in Patients with Acute Stroke: Trends from 8-Year Data of a Large Stroke Register.
    Suntrup-Krueger S; Minnerup J; Muhle P; Claus I; Schröder JB; Marian T; Warnecke T; Kalic M; Berger K; Dziewas R
    Cerebrovasc Dis; 2018; 45(3-4):101-108. PubMed ID: 29533960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland.
    Karliński M; Kobayashi A; Litwin T; Sobolewski P; Fryze W; Romanowicz S; Glonek M; Nyka W; Lisewski P; Członkowska A;
    Neurol Neurochir Pol; 2012; 46(1):3-14. PubMed ID: 22426757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Even Faster Door-to-Alteplase Times and Associated Outcomes in Acute Ischemic Stroke.
    Jung S; Rosini JM; Nomura JT; Caplan RJ; Raser-Schramm J
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104329. PubMed ID: 31607439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACT-FAST: a quality improvement project to increase the percentage of acute stroke patients receiving intravenous thrombolysis within 60 minutes of arrival at the emergency department.
    Chiu LQ; Quek DYJ; Salihan RB; Ng WM; Othman RB; Lee CH; Oh DCT
    Singapore Med J; 2021 Sep; 62(9):476-481. PubMed ID: 32227791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic.
    Agarwal S; Scher E; Rossan-Raghunath N; Marolia D; Butnar M; Torres J; Zhang C; Kim S; Sanger M; Humbert K; Tanweer O; Shapiro M; Raz E; Nossek E; Nelson PK; Riina HA; de Havenon A; Wachs M; Farkas J; Tiwari A; Arcot K; Parella DT; Liff J; Wu T; Wittman I; Caldwell R; Frontera J; Lord A; Ishida K; Yaghi S
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105068. PubMed ID: 32807471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007150. PubMed ID: 33302714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
    Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.